"Vasopressins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antidiuretic hormones released by the NEUROHYPOPHYSIS of all vertebrates (structure varies with species) to regulate water balance and OSMOLARITY. In general, vasopressin is a nonapeptide consisting of a six-amino-acid ring with a cysteine 1 to cysteine 6 disulfide bridge or an octapeptide containing a CYSTINE. All mammals have arginine vasopressin except the pig with a lysine at position 8. Vasopressin, a vasoconstrictor, acts on the KIDNEY COLLECTING DUCTS to increase water reabsorption, increase blood volume and blood pressure.
| Descriptor ID |
D014667
|
| MeSH Number(s) |
D06.472.699.631.692.781 D12.644.400.900 D12.644.456.925 D12.644.548.691.692.781 D12.776.631.650.937
|
| Concept/Terms |
Vasopressins- Vasopressins
- beta-Hypophamine
- beta Hypophamine
- Antidiuretic Hormones
|
Below are MeSH descriptors whose meaning is more general than "Vasopressins".
Below are MeSH descriptors whose meaning is more specific than "Vasopressins".
This graph shows the total number of publications written about "Vasopressins" by people in this website by year, and whether "Vasopressins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 2 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 2 | 3 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vasopressins" by people in Profiles.
-
Acute Effects of Vasopressin Arginine Infusion in Children with Congenital Heart Disease: Higher Blood Pressure Does Not Equal Improved Systemic Oxygen Delivery. Pediatr Cardiol. 2021 Dec; 42(8):1792-1798.
-
Intensive care management of right ventricular failure and pulmonary hypertension crises. Pediatr Pulmonol. 2021 03; 56(3):636-648.
-
Vasopressin in neonatal hypertrophic cardiomyopathy: do perceived benefits translate to clinical outcome? J Perinatol. 2021 04; 41(4):905-906.
-
Effects of Vasopressin Infusion After Pediatric Cardiac Surgery: A Meta-analysis. Pediatr Cardiol. 2021 Feb; 42(2):225-233.
-
Safety and Efficacy of Vasopressin After Fontan Completion: A Randomized Pilot Study. Ann Thorac Surg. 2019 12; 108(6):1865-1874.
-
Reply: To PMID 25641242. J Pediatr. 2015 Aug; 167(2):499.
-
Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study. J Pediatr. 2015 Apr; 166(4):850-5.
-
Trends in pharmacotherapy for neonatal hypotension. J Pediatr. 2014 Oct; 165(4):697-701.e1.
-
Exogenous Vasopressin-Induced Hyponatremia in Patients With Vasodilatory Shock: Two Case Reports and Literature Review. J Intensive Care Med. 2015 Jul; 30(5):253-8.
-
Analysis of transcription factor mRNAs in identified oxytocin and vasopressin magnocellular neurons isolated by laser capture microdissection. PLoS One. 2013; 8(7):e69407.